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Abstract Insulin receptors (IRs) that are truncated at the end of
the ectodomain form dimers that bind insulin with different
characteristics to wild type receptors. These soluble IRs have
lowered affinity for insulin compared with full-length IR, and
exhibit linear Scatchard plots in contrast to the curvilinear plots
obtained with full-length IR, IR truncated at the C-terminus of
the transmembrane region and IR ectodomains fused to the self-
associating constant domains from Fc or V immunoglobulins. In
this report, we have fused the IR ectodomain to the 33 residue
leucine zipper from the transcriptional activator GCN4 of
Saccharomyces cerevisiae. This fusion protein binds insulin with
high affinity in a manner comparable to native receptor. The
respective dissociation constants were Kd1 8.2U10311 M and Kd2
1.6U1038 M for hIRedZip and Kd1 5.7U10311 M and Kd2
6.3U1039 M for membrane-anchored, native receptor. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
The insulin receptor (IR) is synthesized as a disul¢de-linked
homodimer that is post-translationally cleaved to yield two K-
and two L-chains. There are at least two K^K disul¢de bonds
linking the monomers in the dimer [1^3] and a single disul¢de
bond linking the K- and L-chains within each monomer [3].
The K-chain is exclusively extracellular while the L-chain con-
tains extracellular and intracellular regions linked by a single
transmembrane domain of 23 amino acids. The K-chains carry
the major determinants for insulin binding with residues from
four distinct regions, the L1 domain, Cys-rich region, L2 do-
main and the insert domain, contributing to the interaction
with ligand [4^6].
Many studies of insulin binding to native, membrane bound
IR have indicated the existence of high and low a⁄nity bind-
ing states [7]. In contrast, secreted IRs that are truncated at
the ectodomain/transmembrane junction form dimers with
only low a⁄nity for insulin and exhibit linear Scatchard plots,
in contrast to curvilinear plots obtained for the full-length
receptor [7^10]. Analysis of the binding characteristics of a
series of truncated hIR receptors with progressive C-terminal
deletions revealed that truncation at the C-terminal end of the
transmembrane region (residues 1^952) was su⁄cient for the
generation of curvilinear Scatchard plots, high a⁄nity binding
and negative cooperativity [11]. These data imply that a pre-
cise orientation of the C-terminal region of the ectodomain is
required to facilitate the conformational changes required for
high a⁄nity. Subsequently, wild type receptor binding char-
acteristics were obtained with soluble IR ectodomain fusion
proteins, where the self-associating, constant domains from
either immunoglobulin Fc (244 amino acids) or V (103 amino
acids) domains were placed at the C-terminus [12].
In order to understand the structural basis of ligand-in-
duced signal transduction, structural information is required
for di¡erent forms of the receptor. These are: the uncom-
plexed receptor, the low a⁄nity complex of ectodomain or
ectodomain fragments and receptor constructs capable of ex-
hibiting the high a⁄nity binding with ligand. In this report,
we have placed a 33 amino acid leucine zipper from the
GCN4 transcriptional activator of Saccharomyces cerevisiae
[13] at the C-terminal end of the exon 11 minus form of the
human IR (hIR) ectodomain. This enables the production of a
soluble form of the hIR ectodomain dimer that exhibits high
a⁄nity insulin binding and curvilinear Scatchard plots. Leu-
cine zippers have been used previously to promote the assem-
bly of KL heterodimers of the IL2 receptor [14] and the T cell
receptor [15].
2. Materials and methods
2.1. Expression constructs hIRed and hIRedZip
The exon 11 minus form of hIR ectodomain/leucine zipper fusion
(hIRedZip) was generated via the following stepwise procedure. A 4.2
kb SalI/Xba restriction fragment, isolated from the plasmid peT [16], a
gift from Dr. W.J. Rutter, UCSF, which encoded hIR (exon 11+
form), was inserted into the SalI/XbaI cut and dephosphorylated
pBluescript KS+ plasmid vector (Pharmacia). The resultant 7.1 kb
plasmid pBluhIR contained a single SalI/XbaI inserted fragment of
hIR cDNA. Single-stranded circular DNA derived from pBluhIR was
modi¢ed by site-directed mutagenesis using an oligonucleotide anti-
sense primer 5P-GGCCCATCTGGCTGGCTAGCAATATTTGAC-
GGG-3P. This mutagenesis produced a plasmid phIRvTM in which
the nucleotide sequence that encoded both the transmembrane and the
£anking Lys and Arg residues (amino acids 929^953) of hIR 11+ was
replaced by a sequence which encoded a single Ser residue, and pro-
vided a unique NheI restriction site. This exon 11+ construct was
converted to an exon 113 version by exchanging the 1.8 kb AatII
fragment from phIRvTM with the equivalent AatII fragment from
plasmid pHIR/P12-1 (ATCC 57493; nucleotides 1101^2861 that en-
coded part of the extracellular domain and the entire cytoplasmic
domain of the hIR exon 113 form [17]) to produce plasmid pEZI-1
which lacks the 36 nucleotides of exon 11. DNA which encoded the
leucine zipper of the transcriptional activator GCN4 and a termina-
tion codon was ampli¢ed from S. cerevisiae S288C genomic DNA by
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polymerase chain reaction (PCR) using the oligonucleotide primers:
5P-TGAAGCTAGCAGAATGAAACAACTTGAAG-3P and 5P-TG-
AATCTAGATCAGCGTTCGCCAAC-3P (NheI and XbaI sites are
underlined). The PCR fragment (V100 bp) was digested with NheI/
XbaI and ligated to NheI/XbaI-digested and dephosphorylated pEZI-1
to produce the 6.1 kb plasmid pEZI-2 which contained hIR exon 113
ectodomain fused to the leucine zipper.
The mammalian expression plasmid phIRedZip was constructed by
exchanging the 1.1 kb BamHI/XbaI fragment from pEZI-2 for the
corresponding fragment from plasmid pEH3, a derivative of the mam-
malian expression plasmid pEE14 (CellTech Ltd., Slough, UK), which
contained the entire coding sequence for hIR exon 113 and from
which the two EcoRI sites and a BamHI site located outside the
hIR coding region had been sequentially removed (not shown). All
plasmid constructions were veri¢ed by restriction endonuclease anal-
ysis. Mutagenized regions and sequence which surrounded ligation
junctions were con¢rmed by nucleotide sequencing.
The construction of the expression plasmid (pIRII) for the non-
zippered hIR ectodomain, exon 113 form (hIRed) has been described
previously [18,19].
2.2. Cell culture, DNA transfection and protein production
Chinese hamster ovary cells (CHO-K1) and the glycosylation de¢-
cient Lec8 cells were transfected with pIRII and phIRedZip using
Lipofectamine (Gibco-BRL) and maintained in glutamine-free Glas-
cow modi¢cation of Eagle’s medium (GMEM) from ICN Biomedi-
cals, Australia, and 10% dialyzed fetal calf serum (FCS) containing 25
WM methionine sulfoximine (MSX) as previously described [19,20].
Transfected cells were screened for expression by a sandwich, en-
zyme-linked immunosorbent assay as described previously [19,20].
Cell lines producing the highest levels of secreted receptor were cloned
by limiting dilution. Selected clones (inoculum of V1.328U108 cells)
were grown in spinner £asks packed with 10 g of Fibra-Cel disks
(Sterilin, UK) as carriers and ¢lled with 500 ml of GMEM medium
containing 10% FCS and 25 WM MSX. Selection pressure, using
MSX, was maintained for the duration of the culture. The expressed
hIRedZip fusion protein and hIR ectodomain (hIRed) were puri¢ed
from conditioned media by a⁄nity chromatography on immobilized
bis-butyloxycarbonyl-insulin (bis(BOC)-insulin) and serial elution
with 0.4 M NaCl/0.2 M trisodium citrate (pH 5.0) followed by insulin
in Tris-bu¡ered saline containing 0.02% sodium azide (TBSA) pH 8.0,
and 0.1 M trisodium citrate pH 3.0 into tubes containing su⁄cient 1 M
Tris^HCl at pH 8.0 to neutralize the fractions [8]. Eluted fractions
were concentrated by ultra¢ltration and puri¢ed by gel ¢ltration chro-
matography on a column of Superdex S200 (Pharmacia; 1U40 cm) in
TBSA as described previously [20]. Final separation of monomeric
hIRedZip from aggregated material was achieved by ion-exchange
chromatography on Resource Q (Pharmacia). Solutions of puri¢ed
hIRedZip and hIRed were stored at 4‡C prior to use. Metabolic label-
ling, sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^
PAGE), solid-plate insulin binding assays and Scatchard analyses
were performed at least three times in triplicate as described previ-
ously [19,20]. Ligand binding data were analyzed using the LIGAND
program [21].
3. Results
Puri¢ed hIRedZip protein expressed in Lec8 cells and pu-
ri¢ed by a⁄nity chromatography on a bis(BOC)-insulin a⁄n-
ity column ran as two overlapping peaks of V750 kDa and
430 kDa, respectively, on a Superdex S200 gel ¢ltration col-
umn, indicating the presence of aggregated material (not
shown). The ratio of aggregated to non-aggregated material
was approximately 2:1 in the pH 5.0 eluted material and 1:2
in the insulin-eluted protein. The aggregated material could be
readily separated from the non-aggregated hIRedZip protein
by ion-exchange chromatography on Resource Q (Fig. 1).
Rechromatography on the Superdex S200 gel ¢ltration col-
umn showed that peak 1 from the ion-exchange column con-
tained the aggregates while the material in peak 2 contained
hIRedZip which eluted at a similar position to the non-zip-
pered hIRed [18,20]. SDS^PAGE of puri¢ed samples of hIR-
edZip and hIRed under reducing and non-reducing conditions
con¢rmed that both proteins are disul¢de-linked dimers com-
prised of K- and LP-chains of apparent masses Mr 120 kDa
and 33^50 kDa, respectively.
The insulin binding characteristics of zippered and non-zip-
pered hIR ectodomains were investigated by competitive bind-
ing assays and compared with those of wild type whole re-
ceptor from CHO-T cells. Similar results were obtained with
conditioned medium and highly puri¢ed protein samples pro-
duced by fermentation. The Scatchard transformations of the
displacement curves are shown in Fig. 2. The non-zippered
hIRed gave linear Scatchard plots and Kd of 1.1 þ 0.1U1038
M (mean þ S.E.M.). In contrast, hIRedZip gave curvilinear
Scatchard plots and Kd values of 8.2 þ 1.5U10311 M and
1.6 þ 0.2U1038 M for a two state ¢t similar to the values of
5.7 þ 0.9U10311 M and 6.3 þ 0.9U1039 M obtained for native
whole IR (Fig. 2).
4. Discussion
In contrast to most receptor tyrosine kinases, where ligand
binding induces dimerization and transphosphorylation [22],
the IR already exists as a preformed, disul¢de-linked dimer in
its basal state. It is induced to undergo autophosphorylation
following ligand binding by a process that is still poorly
understood. Insulin binding to detergent-solubilized whole
IR induces conformational changes (as assessed by a decrease
in the Stokes radius from 9.1 nm to 7.5 nm and an increase in
the sedimentation coe⁄cient (S20.w) from 10.1 S to 11.4 S)
which correlated with the onset of autophosphorylation of the
kinase domain [23]. The 9.1 nm form of the (KL)2 IR is re-
stored following dissociation of the ligand without reduction
in the kinase activity of the now autophosphorylated cytoplas-
Fig. 1. Ion-exchange chromatography of a⁄nity-puri¢ed hIRedZip.
Protein obtained from the pH 5 elution as in Fig. 2 was loaded
onto a Resource Q column (Pharmacia) ¢tted to a BioLogic L.C.
system (Bio-Rad) in 20 mM Tris/pH 8.0 and eluted at 1 ml/min
with a linear gradient of the same bu¡er against that containing 1 M
NaCl as bu¡er B. Elution was monitored by absorbance (280 nm)
and conductivity (mS/cm). Fractions eluting in peak 1 were concen-
trated and when this fraction was rerun over a Superdex S200 col-
umn, it eluted in the position of the V430 kDa protein (not
shown). Conversely, protein eluting in peak 2 on Resource Q was
shown to correspond to protein of mass 750 kDa on S200 (not
shown).
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mic domains. In contrast, solubilized KL half-receptors do not
show altered conformation on binding insulin nor is their ki-
nase activity induced [23]. Similarly, there are marked di¡er-
ences in the insulin binding characteristics of the (KL)2 dimer
versus the KL monomer. The (KL)2 dimer displays complex
binding characteristics including curvilinear Scatchard plots,
indicative of two binding states (high and low a⁄nity) and
negative cooperativity [7,23]. In contrast, the KL half-recep-
tors exhibit linear Scatchard plots consistent with a simple
one-class insulin binding state which has relatively low a⁄nity
[23]. Collectively, these data indicate that interaction between
the two KL monomers is required for the generation of high
a⁄nity binding and ligand-induced signal transduction.
Although ectodomain constructs are (KLP)2 dimers, they
resemble the KL half-receptors in their binding characteristics
and do not show high a⁄nity binding [8]. In contrast, IR
constructs which terminate after the transmembrane domain
[11], or IR ectodomain constructs with either the Fc or V
immunoglobulin domains [12] attached to the C-terminus, ex-
hibit curvilinear Scatchard plots similar to those found with
the wild type receptor. In this report, we have shown that the
leucine zipper sequence from the yeast transcriptional activa-
tor protein GCN4 can be used to regenerate the high a⁄nity
binding characteristics of whole receptor.
A common factor in all of these constructs is the presence
of a ‘tethering’ dimerization domain (or a membrane-em-
bedded K-helix) whose function appears to be to bring the
C-termini of the adjacent monomer chains into close proxim-
ity. This intimate association appears to be a necessary pre-
condition for both high a⁄nity insulin binding and negative
cooperativity to occur.
The molecular basis of the negative cooperativity observed
with the IR [7] is still unclear but some insights into this
phenomenon can be obtained from the Salmonella typhimuri-
um aspartate receptor whose three-dimensional (3D) structure
has been solved [24,25]. This receptor, like the IR, is a trans-
membrane protein that undergoes conformational change on
binding ligand, resulting in the activation of a protein kinase
(CheA) leading to signal transduction [26]. The aspartate re-
ceptor, like the IR, is a homodimer with two identical binding
sites at the dimer interface. In the ligand/receptor complex,
only one site is occupied by aspartate, which makes contacts
with residues from both monomers. The e¡ect of aspartate
binding is to bring the two monomers slightly closer together
and to make the second (empty) site more crowded so that it
cannot accommodate ligand [24,25].
The aspartate receptor may serve as a good model for neg-
ative cooperativity in the IR family. The non-zippered hIR
ectodomain has two identical binding sites and binds two
insulin molecules with equal a⁄nity that is 20 times lower
than the high a⁄nity of the whole receptor [8]. The whole
IR (KL)2 dimer, like the aspartate receptor, binds only one
ligand molecule with high a⁄nity. A cross-linking model has
been proposed [7,27] to explain this behavior where, in the
high a⁄nity state, insulin makes contact with distinct regions
of the two monomers in the IR dimer. Negative cooperativity
follows if the receptor dimer has internal symmetry [7] and
binding of ligand in one site causes conformational change
that precludes ligand binding at the second site.
Structural support for internal symmetry has come from
electron microscopy studies that show the IR dimer has 2-
fold symmetry with the 2-fold axis normal to the membrane
surface [18,28]. The 3D structure of the L1/Cys-rich/L2 do-
mains of the insulin-like growth factor-1 receptor reveals that
these three domains, which contain many of the determinants
of ligand binding, surround a central space of su⁄cient size to
accommodate a ligand molecule [6]. It is tempting to speculate
that, as for the aspartate receptor, ligand binding at one site
Fig. 2. Insulin binding to IR and IR ectodomain variants. Detergent
lysates of CHO-T cells or culture supernatants from cells expressing
hIRed and hIRedZip were incubated in microtiter plates precoated
with IR speci¢c monoclonal antibody 83-14. [125I]Tyr A14 insulin
and varying concentrations of unlabelled insulin were added to wells
containing immobilized receptors. After thorough washing, radioac-
tivity remaining in each well was determined and the data obtained
were analyzed using the LIGAND program and displayed using the
method of Scatchard (plots shown are representative of at least six
analyses). To assist comparison, both bound ligand (B) and bound/
free ligand (B/F) have been divided by R0 (the total receptor con-
tent of each receptor preparation as determined by analysis of data
using the LIGAND program).
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leads to contacts with key residues on both IR monomers.
These contacts induce a subtle re-arrangement in the orienta-
tion of the two monomers where the corresponding contact
residues in the unoccupied binding site crowd each other in
such a way that a ligand molecule can no longer be accom-
modated at that second site. Direct structural information is
required to address this point and the leucine zippered ecto-
domain fragment described here, or the Fc or V constructs [12]
are potential candidates for crystal production and structural
analysis of high a⁄nity receptor/ligand complexes.
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